Everest Medicines
Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address c...
Searching…
Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address c...
Find the latest Everest Medicines Limited (1952.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sep 2, 2025 · 云顶新耀是一家聚焦肾病/自身免疫与抗感染领域的 生物医药 公司,已在中国商业化两款产品:NEFECON®(布地奈德靶向小肠回肠释放制剂,用于IgA肾病)和XERAVA®(厄拉他环素,抗复杂腹腔内感染)。
Nov 13, 2025 · Everest Medicines Limited, a biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Grea...
Aug 28, 2025 · About Everest Medicines Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that ad...
公司概况公司概况 云顶新耀是一家在香港上市(HKEX 1952.HK),专注于创新药和疫苗研发、临床开发、制造及商业化的生物制药公司,致力于满足大中华区和其他亚洲市场尚未满足的医疗需求。云顶新耀的管理团队在中国及全球制药企业从事过高质量研发、临床开发、药政事务、化学制造与控制 (CMC ...
Jun 21, 2025 · Everest Medicines是一家生物制药公司,专注于发现、开发、生产和商业化能够满足亚洲市场患者关键未满足医疗需求的变革性医药产品和疫苗。